**RFK Jr. serves as HHS Secretary in the Trump administration, confirmed by the Senate in February 2025 for a term extending through 2029.** Trader consensus heavily favors him remaining in the role past October 31, 2026, reflecting sustained White House backing and the absence of procedural or political triggers for departure. President Trump has publicly endorsed Kennedy’s leadership amid ongoing MAHA initiatives, including vaccine policy revisions, HHS reorganization, and chronic disease priorities, with the president hosting him at the White House and aligning on related messaging this year. Recent activity includes Kennedy’s September 5, 2026, congressional testimony on the FY 2026 HHS budget and continued agency leadership despite external criticism and calls for resignation from some health organizations. No Senate confirmation dynamics, major scandals, or administration signals point to an imminent exit, and Kennedy has stated he has no plans to pursue higher office in 2028. While isolated reports have noted variable engagement levels, the core political alignment and institutional continuity support the current pricing.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว6% โอกาส
ใหม่
ใหม่
Oct 31, 2026
6% โอกาส
ใหม่
ใหม่
Oct 31, 2026
This market will resolve to “Yes” if Robert F. Kennedy Jr. (RFK Jr.) ceases to be United States Secretary of Health and Human Services (HHS) for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.**RFK Jr. serves as HHS Secretary in the Trump administration, confirmed by the Senate in February 2025 for a term extending through 2029.** Trader consensus heavily favors him remaining in the role past October 31, 2026, reflecting sustained White House backing and the absence of procedural or political triggers for departure.
President Trump has publicly endorsed Kennedy’s leadership amid ongoing MAHA initiatives, including vaccine policy revisions, HHS reorganization, and chronic disease priorities, with the president hosting him at the White House and aligning on related messaging this year. Recent activity includes Kennedy’s September 5, 2026, congressional testimony on the FY 2026 HHS budget and continued agency leadership despite external criticism and calls for resignation from some health organizations.
No Senate confirmation dynamics, major scandals, or administration signals point to an imminent exit, and Kennedy has stated he has no plans to pursue higher office in 2028. While isolated reports have noted variable engagement levels, the core political alignment and institutional continuity support the current pricing.
This market will resolve to “Yes” if Robert F. Kennedy Jr. (RFK Jr.) ceases to be United States Secretary of Health and Human Services (HHS) for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
ตลาดเปิดเมื่อ: Sep 3, 2026, 9:28 AM ET
ปริมาณการซื้อขาย
$23วันสิ้นสุด
Oct 31, 2026ตลาดเปิดเมื่อ
Sep 3, 2026, 9:28 AM ETผู้ตัดสินผล
0x65070BE91...This market will resolve to “Yes” if Robert F. Kennedy Jr. (RFK Jr.) ceases to be United States Secretary of Health and Human Services (HHS) for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.**RFK Jr. serves as HHS Secretary in the Trump administration, confirmed by the Senate in February 2025 for a term extending through 2029.** Trader consensus heavily favors him remaining in the role past October 31, 2026, reflecting sustained White House backing and the absence of procedural or political triggers for departure.
President Trump has publicly endorsed Kennedy’s leadership amid ongoing MAHA initiatives, including vaccine policy revisions, HHS reorganization, and chronic disease priorities, with the president hosting him at the White House and aligning on related messaging this year. Recent activity includes Kennedy’s September 5, 2026, congressional testimony on the FY 2026 HHS budget and continued agency leadership despite external criticism and calls for resignation from some health organizations.
No Senate confirmation dynamics, major scandals, or administration signals point to an imminent exit, and Kennedy has stated he has no plans to pursue higher office in 2028. While isolated reports have noted variable engagement levels, the core political alignment and institutional continuity support the current pricing.
This market will resolve to “Yes” if Robert F. Kennedy Jr. (RFK Jr.) ceases to be United States Secretary of Health and Human Services (HHS) for any period of time between market creation and the specified date (ET). Otherwise, this market will resolve to “No”.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
ปริมาณการซื้อขาย
$23วันสิ้นสุด
Oct 31, 2026ตลาดเปิดเมื่อ
Sep 3, 2026, 9:28 AM ETผู้ตัดสินผล
0x65070BE91...**RFK Jr. serves as HHS Secretary in the Trump administration, confirmed by the Senate in February 2025 for a term extending through 2029.** Trader consensus heavily favors him remaining in the role past October 31, 2026, reflecting sustained White House backing and the absence of procedural or political triggers for departure. President Trump has publicly endorsed Kennedy’s leadership amid ongoing MAHA initiatives, including vaccine policy revisions, HHS reorganization, and chronic disease priorities, with the president hosting him at the White House and aligning on related messaging this year. Recent activity includes Kennedy’s September 5, 2026, congressional testimony on the FY 2026 HHS budget and continued agency leadership despite external criticism and calls for resignation from some health organizations. No Senate confirmation dynamics, major scandals, or administration signals point to an imminent exit, and Kennedy has stated he has no plans to pursue higher office in 2028. While isolated reports have noted variable engagement levels, the core political alignment and institutional continuity support the current pricing.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย